Humanitarian project will set up infrastructure, provide expert
training, validate and process samples
GLASGOW, Scotland, Jan. 30, 2013 /CNW/ - Life Technologies Corporation (NASDAQ: LIFE) today announced it will provide a complete
laboratory solution to identify an estimated 20,000 human remains found
in various mass graves in Libya following the uprising of 2011 and to
address missing persons cases from the 42-year regime of Muammar
Gaddafi. This identification work is expected to take several years.
(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO )
Life Technologies, a leader in forensic DNA technologies, will provide
the infrastructure, including the expertise, training, and the forensic
instruments and materials to validate the workflow and process DNA
samples through its Dubai-based distributor Integrated Gulf Biosystems (IGB).
"It is our hope that many families will find the answers to what
happened to their loved ones," said Peter Silvester, President, Life
Technologies, Europe, Middle East & Africa. "By providing the
laboratory setup and forensic expertise we will help train Libyan
scientists in the very latest instruments, technology and protocols to
enable them in their work and help promote reconciliation in Libya."
Life Technologies will create two separate DNA lines - one geared toward
reference samples and the second focusing on processing samples from
human remains. Fifty-thousand samples will be processed per year.
Human remains samples will be processed using PrepFiler® BTA chemistry optimized to isolate DNA from bones and teeth in combination
with AmpFlSTR® NGM SElect™ PCR Amplification Kit and MiniFiler™ Kit, designed for heavily degraded samples. Reference samples will be
processed using direct amplification technology combining Copan NUCLEIC-CARD™ with NGM SElect™ Express.
The laboratory will utilise the latest generation of genetic analysers
and ancillary equipment and will be functionally validated under the
quality assurance standards and guidelines required by the ASCLAD-LAB,
SWGDAM and ISO 17025. Some training of Libyan scientists will take
place in the United States under the direction and supervision of Dr. Arthur Eisenberg, a world renowned forensic scientist, leading up to the lab's opening
"The University of North Texas Health Science Center, with its extensive experience in the identification of missing persons
and human decedents, is extremely pleased to partner with Life
Technologies in the training of the Libyan forensic scientists to help
them complete their mission," said Dr. Eisenberg, Director of the UNT Center for Human Identification.
The humanitarian project is funded in part by Repsol, a Spanish-based oil company which donated to the Libyan government
through its foundation, $2.5 million in 2012 to help establish a
state-of-the-art laboratory to identify and generate profiles from
human remains and references from associated relatives of missing
AmpFlSTR® NGM SElect™ PCR Amplification Kit, Copan NUCLEIC-CARD™, MiniFiler™ Kit and NGM SElect™ Express are for forensic and paternity use only. PrepFiler® BTA is for research use only, not for use in diagnostic procedures.
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160
countries using its innovative solutions to solve some of today's most
difficult scientific challenges. Quality and innovation are accessible
to every lab with its reliable and easy-to-use solutions spanning the
biological spectrum, with more than 50,000 products for agricultural
biotechnology, translational research, molecular medicine and
diagnostics, stem cell-based therapies, forensics, food safety and
animal health. Its systems, reagents and consumables represent some of
the most cited brands in scientific research including: Ion Torrent™,
Applied Biosystems®, Invitrogen™, Gibco®, Ambion®, Molecular Probes®
and Novex®. Life Technologies employs approximately 10,400 people and
upholds its ongoing commitment to innovation with more than 4,000
patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011.
Visit us at our website: http://www.lifetechnologies.com.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our
anticipated results that involve risks and uncertainties. Some of the
information contained in this press release, including, but not limited
to, statements as to industry trends and Life Technologies' plans,
objectives, expectations and strategy for its business, contains
forward-looking statements that are subject to risks and uncertainties
that could cause actual results or events to differ materially from
those expressed or implied by such forward-looking statements. Any
statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan,"
"intend," "anticipate," "target," "estimate," "expect" and the like,
and/or future tense or conditional constructions ("will," "may,"
"could," "should," etc.), or similar expressions, identify certain of
these forward-looking statements. Important factors which could cause
actual results to differ materially from those in the forward-looking
statements are detailed in filings made by Life Technologies with the
Securities and Exchange Commission. Life Technologies undertakes no
obligation to update or revise any such forward-looking statements to
reflect subsequent events or circumstances.
SOURCE: Life Technologies
For further information:
Media Contacts: David Robertson, Corporate Communications, Europe Middle East & Africa; Life Technologies, Email: email@example.com, Tel: +44(0)141-814-5889; Patty Zamora, Corporate Communications (US), Life Technologies Email: firstname.lastname@example.org, Tel: +1-7604767818